Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Thorac Cardiovasc Surg ; 66(8): 667-669, 2018 11.
Artigo em Inglês | MEDLINE | ID: mdl-29954029

RESUMO

Filming surgeries for teaching purposes, publications, and patient records has become increasingly popular as the systems for digital recording have evolved, becoming high-quality systems, both smaller and lighter. Digital recording allows long-term storage, retrieval, and database organization. In addition, sharing digital contents has also become easier since video sharing sites and social networks make it possible to upload these contents onto the Internet. We describe a simple and economical system for surgeons to record surgeries in high definition under sterile conditions without any interference with the surgeon's line of vision.


Assuntos
Salas Cirúrgicas , Cirurgiões , Procedimentos Cirúrgicos Operatórios , Gravação em Vídeo/instrumentação , Documentação/métodos , Educação Médica/métodos , Desenho de Equipamento , Humanos , Cirurgiões/educação , Procedimentos Cirúrgicos Operatórios/educação , Análise e Desempenho de Tarefas
2.
Transplant Proc ; 40(9): 3027-30, 2008 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19010181

RESUMO

INTRODUCTION: Safety of treatment with mammalian target of rapamycin inhibitors (mTORi) in the postoperative period after heart transplantation (HT) is controversial. METHODS: We evaluated the incidence of postoperative complications (pericardial, pleural, and surgical wound complications) among nine de novo heart transplant recipients treated with mTORi compared with 19 patients who did not receive them during the same period (control group). RESULTS: No significant differences were observed between the two groups regarding sex, age, body mass index, pretransplant diagnosis, history of diabetes mellitus, prior cardiac surgery, or baseline renal function. The main laboratory parameters at 1 month were also similar. During the first 2 months after HT, four patients (44%) in the mTORi group developed severe pericardial effusions requiring drainage, compared to 1 (5%) in the control group (P = .026). All patients presenting this complication in the mTORi group received everolimus. In addition, two cases of sternal dehiscence were observed in the mTORi group, compared to none in the control group (P = .09); one patient on everolimus required sternal reopening and debridement for clinically suspected mediastinitis. Duration of chest tube drainage, quantity of collected pleural fluid, and need for thoracentesis were similar in both groups. CONCLUSIONS: In our series, patients receiving mTORi-particularly everolimus-during the postoperative period after HT showed a higher incidence of severe pericardial effusion requiring drainage, as well as a trend toward a higher incidence of sternal dehiscence, as compared to a group not receiving mTORi. The use of mTORi during the early postcardiac transplant period should be individualized.


Assuntos
Transplante de Coração/efeitos adversos , Proteínas Quinases/uso terapêutico , Adulto , Diabetes Mellitus/epidemiologia , Feminino , Transplante de Coração/imunologia , Humanos , Imunossupressores/uso terapêutico , Masculino , Pessoa de Meia-Idade , Seleção de Pacientes , Derrame Pericárdico/epidemiologia , Derrame Pleural/epidemiologia , Período Pós-Operatório , Estudos Retrospectivos , Serina-Treonina Quinases TOR
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...